Theriva Biologics, Inc. financial data

Symbol
TOVX on NYSE
Industry
Pharmaceutical Preparations
Location
9605 Medical Center Drive, Suite 270, Rockville, MD
State of incorporation
NV
Fiscal year end
December 31
Former names
Synthetic Biologics, Inc. (to 10/12/2022), ADEONA PHARMACEUTICALS, INC. (to 2/17/2012), PIPEX PHARMACEUTICALS, INC. (to 10/16/2008), SHEFFIELD PHARMACEUTICALS INC (to 12/8/2006), SHEFFIELD MEDICAL TECHNOLOGIES INC (to 5/14/1997)
Latest financial report
10-Q - Q2 2024 - Aug 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 365 % -23.1%
Return On Equity -33 % -65.8%
Return On Assets -24.7 % -30.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 25.1M shares +47.5%
Common Stock, Shares, Outstanding 22.4M shares +31.4%
Entity Public Float 32.7M USD -58.7%
Common Stock, Value, Issued 23K USD +27.8%
Weighted Average Number of Shares Outstanding, Basic 19.4M shares +27.9%
Weighted Average Number of Shares Outstanding, Diluted 19.4M shares +27.9%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 14.6M USD +24.4%
General and Administrative Expense 5.63M USD -51.2%
Operating Income (Loss) -24.3M USD -4.34%
Nonoperating Income (Expense) 1.09M USD -10.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -23.2M USD -5.16%
Income Tax Expense (Benefit) -1.64M USD -15.1%
Net Income (Loss) Attributable to Parent -3.3M USD +26.4%
Earnings Per Share, Basic -1.23 USD/shares +9.56%
Earnings Per Share, Diluted -1.23 USD/shares +9.56%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 16.6M USD -51.6%
Assets, Current 19.7M USD -48.1%
Property, Plant and Equipment, Net 336K USD +11.6%
Operating Lease, Right-of-Use Asset 1.52M USD -22.3%
Intangible Assets, Net (Excluding Goodwill) 19.2M USD -1.56%
Goodwill 1.47M USD -73.9%
Assets 42.4M USD -35.2%
Accounts Payable, Current 935K USD +26.2%
Employee-related Liabilities, Current 969K USD -9.44%
Accrued Liabilities, Current 3.49M USD +91.1%
Contract with Customer, Liability, Current 906K USD
Liabilities, Current 6.85M USD -25%
Contract with Customer, Liability, Noncurrent 906K USD
Deferred Income Tax Liabilities, Net 413K USD -79.2%
Operating Lease, Liability, Noncurrent 1.16M USD -31%
Liabilities 14.7M USD -16.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax -709K USD -99.2%
Retained Earnings (Accumulated Deficit) -323M USD -7.41%
Stockholders' Equity Attributable to Parent 56.4M USD -23.1%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 25.9M USD -42.5%
Liabilities and Equity 42.4M USD -35.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -4.88M USD +13%
Net Cash Provided by (Used in) Financing Activities -55K USD +96%
Net Cash Provided by (Used in) Investing Activities -8K USD +99.8%
Common Stock, Shares Authorized 350M shares 0%
Common Stock, Shares, Issued 23.1M shares +30.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -4.92M USD +13.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 16.7M USD -51.4%
Deferred Tax Assets, Valuation Allowance 28.4M USD +15.4%
Deferred Tax Assets, Gross 33.3M USD +20.2%
Operating Lease, Liability 1.68M USD -21.6%
Payments to Acquire Property, Plant, and Equipment 8K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -20.4M USD -42.7%
Lessee, Operating Lease, Liability, to be Paid 1.96M USD -25.3%
Property, Plant and Equipment, Gross 1.22M USD -0.89%
Operating Lease, Liability, Current 513K USD +13.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 588K USD -11.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 671K USD +105%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 283K USD -41.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 368K USD -45.4%
Deferred Tax Assets, Operating Loss Carryforwards 27.4M USD +23%
Lessee, Operating Lease, Liability, to be Paid, Year Four 368K USD +3.08%
Operating Lease, Payments 480K USD +51.4%
Depreciation, Depletion and Amortization 39K USD +21.9%
Deferred Tax Assets, Net of Valuation Allowance 4.99M USD +57.5%